tirzepatide increase blood pressure Beyond weight loss, may also lower high pressure: SURMOUNT-1 Tirzepatide for Weight Loss -

Starting elderly patients at 2.5 mg remains appropriate, but extending each dose tier to 6 to 8 weeks rather than 4 weeks improves tolerability

SURMOUNT-1 showed 20.9% mean weight loss at 15 mg, approximately 3-fold greater than liraglutide SCALE results (8.0%)

This comprehensive guide will walk you through the current evidence, official recommendations, and practical considerations to help you make an informed decision about Mounjaro use while nursing your baby

Eli Lillys oral small-molecule GLP-1, orforglipron (Foundayo), was FDA-approved April 1, 2026, but it is not tirzepatide and produces less weight loss (11.2% at 72 weeks)

Consistency matters